Literature DB >> 20223517

Characterization of amine donor and acceptor sites for tissue type transglutaminase using a sequence from the C-terminus of human fibrillin-1 and the N-terminus of osteonectin.

Shih T Khew1, Pradeep P Panengad, Michael Raghunath, Yen W Tong.   

Abstract

Transglutaminase (TGase)-modified proteins are commonly observed in a wide range of biological systems. Therefore, the identification of TGase substrates and respective consensus sites may contribute to a better understanding of the physiological role of TGase. In this study, we identified enzyme-specific properties of two peptide sequences, EDGFFKI, derived from human fibrillin-1, and the previously characterized APQQEA, derived from human osteonectin. EDGFFKI was identified in a previous publication as an amine donor substrate for tissue TGase; APQ(3)Q(4)EA is an amine acceptor for this enzyme. A widely-used lysine donor mimic, monodansylcadaverine (MDC), was used as a control. EDGFFKI crosslinked specifically only to Q(3) of the acceptor probe. The EDGFFKI sequence also showed enzyme specificity for tissue TGase while no reaction was observed with plasma TGase (Factor XIIIa), consistent with its natural occurrence in vivo. Using this substrate in biotinylated form we demonstrate its value as a tracer probe to detect endogenous TGase activity in human tissues as well as to target potential amine acceptor substrates via an enzyme-directed site-specific labeling. The results of this study show natively derived EDGFFKI and APQQEA are better and more specific indicators of endogenous tissue TGase activity as compared to a small molecule probe; this may be important in diagnostic applications. The specificity with which matrix sequences APQQEA and EDGFFKI interact with tissue TGase but not plasma TGase may also be crucial for understanding and controlling the function of these TGases in vivo and in tissue engineering. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223517     DOI: 10.1016/j.biomaterials.2010.01.094

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Decreased Mechanical Strength and Collagen Content in SPARC-Null Periodontal Ligament Is Reversed by Inhibition of Transglutaminase Activity.

Authors:  Jessica Trombetta-eSilva; Emilie A Rosset; R Glenn Hepfer; Gregory J Wright; Catalin Baicu; Hai Yao; Amy D Bradshaw
Journal:  J Bone Miner Res       Date:  2015-05-10       Impact factor: 6.741

3.  Developmental basis for filamin-A-associated myxomatous mitral valve disease.

Authors:  Kimberly Sauls; Annemarieke de Vlaming; Brett S Harris; Katherine Williams; Andy Wessels; Robert A Levine; Susan A Slaugenhaupt; Richard L Goodwin; Luigi Michele Pavone; Jean Merot; Jean-Jacques Schott; Thierry Le Tourneau; Thomas Dix; Sean Jesinkey; Yuanyi Feng; Christopher Walsh; Bin Zhou; Scott Baldwin; Roger R Markwald; Russell A Norris
Journal:  Cardiovasc Res       Date:  2012-07-25       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.